Business UpdateJun 12, 2026, 04:12 PM
Lipocine Inc. Hosts KOL Event on Postpartum Depression and LPCN 1154
AI Summary
Lipocine Inc. (LPCN) filed an 8-K report detailing a virtual key opinion leader (KOL) event held on June 12, 2026. The event focused on the unmet needs in postpartum depression and presented the clinical profile of their product candidate, LPCN 1154. The presentation materials from this event have been furnished as an exhibit to the filing and are also accessible via the company's website.
Key Highlights
- Lipocine Inc. hosted a virtual key opinion leader (KOL) event on June 12, 2026.
- The event highlighted unmet needs in postpartum depression.
- The clinical profile of LPCN 1154 was presented during the event.
- A presentation from the event is furnished as Exhibit 99.1 to the 8-K filing.
- A link to the presentation is available on the company's corporate website.
Price Impact
More from LPCN